Molecular Moments Podcast

In this episode of Molecular Moment, host Jim McNally welcomes Davide Molho, the new CEO of BioAgilytix, to discuss his background, interests, and the future of the company. Davide shares his journey from veterinary medicine to entering the pharmaceutical industry and eventually finding his passion for the business side of science. He highlights the importance of the CRO industry in supporting the...

On this episode of Molecular Moments, Dr. Amanda Hays chats with BioAgilytix scientists Dr. Shashank Gorityala, Associate Director of LC/MS Operations from our Durham lab, and Dr. Ben Nie, Scientist III from our San Diego lab. They delve into LC/MS evolution, tech strides, and its role in large molecule bioanalysis. Discover the benefits of LC/MS for protein and biomarker quantification, different...

On this episode of Molecular Moments, Jim McNally, Ph. D., speaks with Adam Stasio, president of  SciMed , whose mission is to craft software that frees their clients to do what they do best: advance cutting-edge technology, improve lives, and effect social change. They discuss their shared passion for problem-solving and how the right mindset helps find solutions to new issues that arise. They ta...

On this episode of Molecular Moments, Chad Briscoe speaks with Dr. David Berkowitz, Director of the Division of Chemistry at the National Science Foundation (NSF) and a Willa Cather Professor of Chemistry at the University of Nebraska-Lincoln, and co-lead of the Nebraska Drug Discovery & Development Pipeline. David shares how he got his early beginnings in science as an undergrad studying endo...

On this episode of Molecular Moments, Chad Briscoe talks with his brother, Rick Briscoe, Senior VP of Safety Assessment and Research Operations at Cerevel Therapeutics.  Rick talks with Chad about how he found his love of the sciences through a scuba diving class in high school, which sparked his interest in biology and led him to take a neuroscience class during his freshman year of college. Rick...

On this episode of Molecular Moments, BioAgilytix Scientific Officers Amanda Hays, Ph. D., and Lynn Kamen, Ph. D. speak with Stephanie Pasas-Farmer, Ph. D., President of both Ariadne Software and BioData Solutions. They discuss how Stephanie went from a career as a bioanalytical chemist to being an entrepreneur in big data and machine learning. They discuss how she became a founder of a company, b...

On this episode of Molecular Moments, Lynn Kamen, Ph. D., and Michelle Miller, Ph. D. DABT discuss their very different journeys to BioAgilytix as Scientific Officers. Despite different initial career paths, they both ended up working in bioanalysis, supporting the development of novel therapeutics. The pair discuss their favorite aspects of their day-to-day tasks at BioAgilytix, Scientific Office...

On this episode of Molecular Moments, Dr. Jim McNally chats with DMPK Senior Director Dr. David Johnson, Ph. D., from BioAgilytix San Diego. They discuss how his childhood breakfast cereal formed an interest in science which eventually led to his pursuit of biochemistry and a career in small molecule therapeutics.  David, known as Dr. J to his friends and colleagues, shares his goal of helpin...

In this episode of Molecular Moments, Dr. Jim McNally chats with Tricia Sterling, Vice President of Patient Affairs at Aeglea. Tricia shares some of her experiences working with patients in the biotech industry for over a decade. Jim and Tricia’s discussion focuses on the patient side of pharmaceutical research, particularly in relation to rare diseases, as they affect 1 out of 15 people wor...

On this episode of Molecular Moments, Scientific Officer Amanda Hayes speaks with BioAgilytix colleague Dr. Dave Williams, Vice President of Operations. Dave has spent the last decade of his career supporting and leading bioanalytical programs at contract research organizations (CROs) in his pursuit of solutions for scientific problems. They discuss what inspired him to study science, his career p...

On this episode of Molecular Moments, Dr. Chad Briscoe is joined by Dr. Kevin Bateman, Scientific Associate and Vice President at Merck. Kevin is a veteran of the bioanalytical industry and is known for innovating and encouraging new technology research. With over 25 years at Merck, Kevin shares a bit about his journey that started in an analytical lab focusing on biomarkers, pharmacology, biology...

On this episode of Molecular Moments, Jim McNally chats with Angela Luttick, co-founder of 360biolabs & Executive Vice President, Commercial. 360biolabs, a BioAgilytix company has labs located in Melbourne and Brisbane and is the most comprehensive specialty lab in the region. They discuss the origins of 360biolabs, its role in early phase clinical...

In this episode of Molecular Moments, Chad Briscoe sits down with Neil Spooner, founder and director of Spooner Bioanalytical Solutions and senior editor of the journal, “Bioanalysis.” Based in England, Neil shares a bit of his background in LC-MS, his first taste of quantitative bioanalysis at Huntingdon Life Sciences, helping organizations understand their own technologies and the ex...

On this episode of Molecular Moments, BioAgilytix Chief Scientific Officer Jim McNally chats with the company’s President & CEO about the exciting new updates that are putting BioAgilytix at the forefront of biotech on a global level. From multiple acquisitions to a new investor that sees the bigger picture, Datin shares how these opportunities came to be and what major deciding factors...

Chad Briscoe and Jim McNally talk with Emmy-winning journalist and producer Charles Sabine on this episode of Molecular Moments. Their discussion centers around rare diseases, gene therapy and Huntington's Disease (HD). Charles, a carrier of the HD gene who has lost several immediate family members to the disease, is an ardent advocate for patients and families suffering from rare degenerative dis...

On this episode of Molecular Moments, Chad Briscoe chats with Dr. Jennifer Zemo, Director, Bioanalytical Operations at BioAgilytix. She’s a great leader, mentor and scientist with a love for helping people and the sciences. They discuss her start as a chemistry major in college, which led to her Ph. D. in Biological Chemistry and eventually to joining BioAgilytix 8 years ago. A large molecul...

In this episode of Molecular Moments, Chad talks with Dr. Afshin Safavi, a bioanalytical thought leader, BioAgilytix founder, and board member. Afshin shares how his interest in the sciences was sparked by his mother's perfumes and household items, and how he went from pursuing a career in electronic engineering to dentistry and then into pharmaceuticals! They also discuss Afshin’s upcoming...

In this episode, Chad sits down with Jeff Sutherland, founder and CEO of Canine Biologics. With over 500,000 dogs in the US and Canada diagnosed with cancer each year, Jeff’s company addresses nutritional needs for dogs to fight terminal diseases based on tumor type. They discuss how Jeff started off as pre-med in college before shifting his focus to marketing, then to dental technology, and...

In today's episode, Chad sits down with guest scientists, Drs. Jolly Mazumdar and Tim Chendrimada, CEO, and CSO of Chimeron Bio. Two different beginnings; one in the sciences studying bugs and infectious diseases and the other in agriculture, specifically coffee beans! They talk to Chad about how their very different paths led them to become a dynamic duo in the next generation of RNA therapeutics...

In today's episode, Chad sits down with guest scientist, Dr. John Smeraglia, Vice President & Head of Translational Biomarkers and Bioanalysis at UCB. John is an experienced pharma leader in the development and service side of the industry. John talks to Chad about his experiences working in the UK, such as picking up basketball and taking apart a massive magnetic sector mass spectrometer in h...

In today’s episode, Chad sits down with Angela Stoyanovitch, a director of business development at BioAgilytix and founder of the Legal Drugs podcast. She’s a podcaster, veteran business developer, social media strategist and consultant who kicked off her career in research who has held business development roles across pre-clinical research, bioanalysis and in basic research. They dis...

In today’s episode, Chad sits down with guest scientist, Dr. Laura Sepp-Lorenzino the Chief Scientific Officer at Intellia Therapeutics. Laura is an innovative leader in drug discovery and the development of small molecules and nucleotide therapeutics. Pharma is in Laura’s blood as her mother, a pharmacist, encouraged her to pursue a career in the science. She shares how she went...

In today’s episode, Chad sits down with guest scientist, Dr. Tina Morris the executive director of the AAPS. Tina has a distinguished career in the pharmaceutical industry including senior leadership roles at US Pharmacopia, Parenteral Drug Association, and the AAPS.  She helps us understand the importance of these industry organizations and how we can make a difference by getting invol...

In today’s episode, Chad sits down with guest Mike Mortimer, co-founder, and partner of London-based GHO Capital. Mike has had a distinguished career in healthcare including senior leadership roles at Quintiles, board positions with numerous healthcare companies including BioAgilitx, and for the last six years with GHO Capitals. At Quintiles he was a part of the team that grew the company to...

In today’s episode, Chad sits down with guest scientist Dr. Binodh DeSilva Lead, Discovery and Optimization at Bristol Myers Squibb. She has 25 years of experience within the pharmaceutical industry and has spent a significant amount of time at pharma giants, Amgen and BMS. Binodh has been highly involved in the pharmaceutical industry and more specifically in bioanalysis for much of her car...